News NHS U-turns on Afinitor for TSC-related epilepsy NHS England has reversed a previous decision and will be funding Novartis’ Afinitor (everolimus)
News GW launches cannabis-based epilepsy drug in US GW Pharmaceuticals is bullish about the company’s prospects following the launch of its cannabis-based medicine for a rare form of childhood epilepsy.
News GW Pharma's marijuana-based epilepsy drug approved in US The FDA has approved UK-based GW Pharmaceuticals' drug for a rare form of childhood epilepsy - the first marijuana-based medicine approved in the US.
News FDA advisers back GW's Epidiolex for rare epilepsy UK firm's potential blockbuster on course for approval
News GW files cannabis-based epilepsy drug in EU and US After Sativex disappointment, Epidiolex could transform GW's fortunes.
News As Ebola deaths climb, search begins for vaccine The WHO has held a closed expert meeting to identify potential vaccines for the Bundibugyo species of Ebola and fast-track clinical trials.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
